PPI co-therapy did not adversely affect outcomes in clopidogrel users
Article first published online: 15 DEC 2011
© 2011 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 35, Issue 2, pages 313–314, January 2012
How to Cite
Leontiadis, G. I. and Howden, C. W. (2012), PPI co-therapy did not adversely affect outcomes in clopidogrel users. Alimentary Pharmacology & Therapeutics, 35: 313–314. doi: 10.1111/j.1365-2036.2011.04935.x
- Issue published online: 15 DEC 2011
- Article first published online: 15 DEC 2011
- 3Recent safety concerns with proton pump inhibitors. J Clin Gastroenterol 2012; in press., , , .
- 7ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 2010; 105: 2533–49., , , et al.